Developing advanced tools for analyzing genetic data in cancer research
Core 2: Bioinformatics/Biostatistics/Genomics
This study is working on a new platform that combines different scientific tools to help understand cancer better by looking at genetic data, which could lead to new insights that might improve treatment options for patients like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanford Burnham Prebys Medical Discovery Institute NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10935869 on NIH RePORTER |
What this research studies
This research focuses on creating a comprehensive platform that integrates bioinformatics, biostatistics, and genomics to analyze genetic data related to cancer. It aims to support various projects by providing tools for both exploratory and hypothesis-driven analyses, helping to identify key molecules and pathways involved in cancer progression. By examining sequencing data, the research will explore changes in mutations and their implications for cancer treatment. Patients may benefit from the insights gained through this integrated approach to understanding cancer biology.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who may have specific genetic alterations or mutations being studied.
Not a fit: Patients with non-cancerous conditions or those not exhibiting relevant genetic markers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of cancer mechanisms and more targeted therapies for patients.
How similar studies have performed: Previous research in bioinformatics and genomics has shown success in identifying critical pathways in cancer, suggesting that this approach is promising.
Where this research is happening
La Jolla, United States
- Sanford Burnham Prebys Medical Discovery Institute — La Jolla, United States (Active)
Researchers
- Principal investigator: Tamayo, Pablo — Sanford Burnham Prebys Medical Discovery Institute
- Study coordinator: Tamayo, Pablo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.